Dionymer Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $8.22M

  • Investors
  • 11

Dionymer General Information

Description

Developer of a biotechnology platform designed to transform biowaste into circular and biodegradable polymer materials that can replace conventional petrochemical plastics. The company's platform offers a proprietary bacterial fermentation process that produces PHA polymers suitable for cosmetic formulations, encapsulation applications, and bioplastics, enabling manufacturers across consumer, industrial, and packaging sectors to use biodegradable materials that align with natural cycles and reduce dependence on fossil-based inputs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 14 Avenue Pey Berland
  • Building C - ENSMAC
  • 33600 Pessac
  • France
+33 07
Primary Industry
Specialty Chemicals
Other Industries
Environmental Services (B2B)
Biotechnology
Corporate Office
  • 14 Avenue Pey Berland
  • Building C - ENSMAC
  • 33600 Pessac
  • France
+33 07

Dionymer Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dionymer Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC 02-Feb-2026 $8.22M Completed Generating Revenue
5. Grant 09-Apr-2025 Completed Generating Revenue
4. Seed Round 12-Dec-2023 Completed Generating Revenue
3. Seed Round 01-Dec-2022 Completed Generating Revenue
2. Accelerator/Incubator 05-Oct-2021 $23.5K $23.5K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Dionymer’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Dionymer Patents

Dionymer Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4658803-A1 Method for obtaining a solution of volatile fatty acids, solution obtained, and use for the production of polyhydroxyalkanoates Pending 31-Jan-2023
WO-2024160870-A1 Method for obtaining a solution of volatile fatty acids, solution obtained, and use for the production of polyhydroxyalkanoates Inactive 31-Jan-2023
FR-3145292-A1 Process for obtaining a solution of volatile fatty acids, solution obtained and use for the production of polyhydroxyalkanoates Pending 31-Jan-2023 C12P7/54

Dionymer Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dionymer Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
BNP Paribas Développement PE/Buyout Minority
Bpifrance Sovereign Wealth Fund Minority
M Capital Partners Growth/Expansion Minority
UI Investissement PE/Buyout Minority
AFI Ventures (Paris) Impact Investing Minority
You’re viewing 5 of 11 investors. Get the full list »

Dionymer FAQs

  • When was Dionymer founded?

    Dionymer was founded in 2021.

  • Where is Dionymer headquartered?

    Dionymer is headquartered in Pessac, France.

  • What is the size of Dionymer?

    Dionymer has 20 total employees.

  • What industry is Dionymer in?

    Dionymer’s primary industry is Specialty Chemicals.

  • Is Dionymer a private or public company?

    Dionymer is a Private company.

  • What is Dionymer’s current revenue?

    The current revenue for Dionymer is .

  • How much funding has Dionymer raised over time?

    Dionymer has raised $10.4M.

  • Who are Dionymer’s investors?

    BNP Paribas Développement, Bpifrance, M Capital Partners, UI Investissement, and AFI Ventures (Paris) are 5 of 11 investors who have invested in Dionymer.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process